Osteoporosis International

, Volume 4, Supplement 1, pp S47–S51

Postmenopausal bone loss and the risk of osteoporosis

  • C. Christiansen


The two most important risk factors for long-term skeletal health are the peak bone mass and the subsequent rate of bone loss. The rate of bone loss after skeletal maturity is determined by both genetic factors and environmental factors. Furthermore, all factors that impair estrogen production will increase bone loss. The present risk of developing osteoporosis and fractures may be assessed by bone mass measurements in the total skeleton, or in local parts of the skeleton such as the spine, hip and forearm, by single-photon/X-ray absorptiometry (SPA or SXA), dual-photon/energy X-ray absorptiometry (DPA or DXA), or quantitative computed tomography (QCT). Furthermore, the rate of bone loss in postmenopausal women may be assessed by means of a number of biochemical markers. The fútúre risk of developing osteoporosis may thus be determined by combining the values for bone mineral content and bone loss.


Biochemical markers Bone loss Future risk Present risk Techniques of bone mass measurements 


  1. 1.
    Johnston CC, Slemenda CW. Peak bone mass, bone loss and risk of fracture. Osteoporosis Int 1994;4 (Suppl 1):S43–5.Google Scholar
  2. 2.
    Melton LJ, Chao EYS, Lane J. Biomechanical aspects of fractures. In: Riggs BL, Melton LJ, editors. Osteoporosis: etiology, diagnosis, and management. New York: Raven Press, 1988:111–31.Google Scholar
  3. 3.
    Jensen GF, Christiansen C, Transbøl I. Fracture frequency and bone preservation in postmenopausal women treated with oestrogen. Obstet Gynecol 1982;60:493–6.Google Scholar
  4. 4.
    Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979;53:277–81.Google Scholar
  5. 5.
    Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980;2:1151–4.Google Scholar
  6. 6.
    Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988;81:1804–9.Google Scholar
  7. 7.
    Ross PD, Wasnich RD, Vogel JM. Detection of prefracture spinal osteoporosis using bone mineral absorptiometry. J Bone Miner Res 1988;3:1–11.Google Scholar
  8. 8.
    Heaney RP, et al. En recherche de la difference (p<0.05). Bone Miner 1986;1:99–114.Google Scholar
  9. 9.
    Gotfredsen A, Pødenphant J, Nørgaard H, Nilas L, Nielsen V-AH, Christiansen C. Accuracy of lumbar spine bone mineral content by dual photon absorptiometry. J Nucl Med 1988;29:248–54.Google Scholar
  10. 10.
    Consensus Development Conference. Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646–50.Google Scholar
  11. 11.
    Scientific Advisory Board of the National Osteoporosis Foundation. J Bone Miner Res 1989; 4 (Suppl 2).Google Scholar
  12. 12.
    Hansen MA, Riis BJ, Overgaard K, Hassager C, Christiansen C. Bone mass measured by photon absorptiometry: comparison of forearm, heel, and spine. Scand J Clin Lab Invest 1990;50:517–23.Google Scholar
  13. 13.
    Mazess R, Cameron JR. Direct readout of bone mineral content using radionuclide absorptiometry. Int J Appl Radiat Isot 1972;23:471–9.Google Scholar
  14. 14.
    Nilas L, Hassager C, Christiansen C. Long-term precision of dual photon absorptiometry in the lumbar spine in clinical settings. Bone Miner 1988;3:305–15.Google Scholar
  15. 15.
    Wahner HW, Dunn WL, Mazess RB, et al. Dual photon Gd-153 absorptiometry of bone. Radiology 1985;156:203–6.Google Scholar
  16. 16.
    Hansen MA, Hassager C, Overgaard K, Marslew U, Riis BJ, Christiansen C. Dual energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine. J Nucl Med 1990;31:1156–62.Google Scholar
  17. 17.
    Kim, et al. Abstract presented at RSNA'89, Chicago 26 November–1 December 1989.Google Scholar
  18. 18.
    Christiansen C, Riis BJ, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1:1105–8.Google Scholar
  19. 19.
    Christiansen C, Riis BJ, Rødbro P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1990;1:35–40.Google Scholar
  20. 20.
    Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987;65:697–702.Google Scholar
  21. 21.
    Civitelli R, Gonnelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 1988;82:1268–74.Google Scholar
  22. 22.
    Hansen MA, Overgaard K, Riis B J, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 1991;303:961–4.Google Scholar
  23. 23.
    Riis BJ. Consensus Development Conference 1993. Diagnosis, prophylaxis and treatment of osteoporosis. Biochemical markers. II Clinical use. Am J Med (Submitted).Google Scholar
  24. 24.
    Hassager C, Jensen SB, Gotfredsen A, Christiansen C. The impact of measurement errors in diagnostic value of bone mass. Osteoporosis Int 1991:1:250–6.Google Scholar

Copyright information

© European Foundation for Osteoporosis 1994

Authors and Affiliations

  • C. Christiansen
    • 1
  1. 1.Center for Clinical and Basic ResearchBallerupDenmark

Personalised recommendations